Effect of ticagrelor-related dyspnea on compliance with therapy in acute coronary syndrome patients
- 1 April 2014
- journal article
- Published by Elsevier in International Journal of Cardiology
- Vol. 173 (1) , 120-121
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Ticagrelor Increases Adenosine Plasma Concentration in Patients With an Acute Coronary SyndromeJACC, 2014
- Cessation of dual antiplatelet treatment and cardiac events after percutaneous coronary intervention (PARIS): 2 year results from a prospective observational studyThe Lancet, 2013
- Why does ticagrelor induce dyspnea?Thrombosis and Haemostasis, 2012
- Viewpoint: Reversible nature of platelet binding causing transfusion-related acute lung injury (TRALI) syndrome may explain dyspnea after ticagrelor and elinogrelThrombosis and Haemostasis, 2012
- Pulmonary Function in Patients With Acute Coronary Syndrome Treated With Ticagrelor or Clopidogrel (from the Platelet Inhibition and Patient Outcomes [PLATO] Pulmonary Function Substudy)The American Journal of Cardiology, 2011
- Characterization of dyspnoea in PLATO study patients treated with ticagrelor or clopidogrel and its association with clinical outcomesEuropean Heart Journal, 2011
- Ticagrelor versus Clopidogrel in Patients with Acute Coronary SyndromesNew England Journal of Medicine, 2009
- Incidence, Predictors, and Outcome of Thrombosis After Successful Implantation of Drug-Eluting StentsJAMA, 2005
- Effects of Clopidogrel in Addition to Aspirin in Patients with Acute Coronary Syndromes without ST-Segment ElevationNew England Journal of Medicine, 2001
- Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE studyThe Lancet, 2001